Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Constitutive activation of the Src-family kinases Fgr and Hck enhances the tumor burden of acute myeloid leukemia cells in immunocompromised mice

Scientific Reports(2025)10.1038/s41598-024-83740-6Source: DataRank Database

Constitutive activation of the Src-family kinases Fgr and Hck enhances the tumor burden of acute myeloid leukemia cells in immunocompromised mice is a research paper published in Scientific Reports (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.10)OA: goldTopics (63)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Li Chen ORCID,Giancarlo Gonzalez-Areizaga,Thomas E. Smithgall ORCID,Sherry T. Shu

Live enrichment

PubMed:39747387 OpenAlex:https://openalex.org/W4406015791

National Institutes of Health

Grant: CA233576

National Institutes of Health

Grant: 3R01CA233576-03S1

Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia

National Institutes of Health

Grant: 1S10OD025011-01A1

Lumina S5 Imaging System for Microbiology and Molecular Genetics

NCI NIH HHS

Grant: R01 CA233576

NIH HHS

Grant: S10 OD025011

FWCI

3.10

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://www.nature.com/articles/s41598-024-83740-6.pdf

publisherhttps://www.nature.com/articles/s41598-024-83740-6.pdf

publisherhttps://www.nature.com/articles/s41598-024-83740-6

journalhttps://doi.org/10.1038/s41598-024-83740-6

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39747387

Fields of Study

Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsUbiquitin and proteasome pathways0301 basic medicine03 medical and health sciencesAnimalsProto-Oncogene Proteins c-hckLeukemia, Myeloid, AcuteHumansMiceCell Line, TumorTumor BurdenGranulocyte-Macrophage Colony-Stimulating FactorProtein Kinase Inhibitorssrc-Family KinasesImmunocompromised HostPhosphorylationProto-Oncogene Proteins

MeSH Terms

AnimalsHumansPhosphorylationProto-Oncogene ProteinsLeukemia, Myeloid, AcuteGranulocyte-Macrophage Colony-Stimulating FactorImmunocompromised Hostsrc-Family KinasesCell Line, TumorTumor BurdenProtein Kinase InhibitorsMiceProto-Oncogene Proteins c-hck

Keywords

Myeloid leukemiaCancer researchTyrosine kinaseProto-oncogene tyrosine-protein kinase SrcKinaseMyeloidLeukemiaCell cultureChemistryBiologyMolecular biologyImmunologyCell biologySignal transductionScienceQRGranulocyte-Macrophage Colony-Stimulating FactorArticleTumor BurdenLeukemia, Myeloid, AcuteMiceImmunocompromised Hostsrc-Family KinasesCell Line, TumorProto-Oncogene ProteinsProto-Oncogene Proteins c-hckMedicineAnimalsHumansPhosphorylationProtein Kinase Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being